Tag Archives: Postpartum

A Primer on Brexanolone (Zulresso) for Postpartum Depression

Since the the Food and Drug Administration (FDA) approved brexanolone as an intravenous infusion for the treatment of postpartum depression last week, we have been deluged with questions from patents, providers and the media regarding this new drug.  Sage Therapeutics plans to market the drug under the name ZULRESSO and plans to launch in the… Read More »

Category: Uncategorized

Timing of Postpartum Depression Onset May Predict Symptom Pattern

Postpartum depression (PPD) is a common and complicated illness, affecting about 15% of women in the perinatal period. Recent research from the PACT consortium (Postpartum Depression: Action Toward Causes and Treatment) has sought to classify the many potential subtypes of this heterogenous illness and has found emerging differences in time of onset, severity, comorbid anxiety,… Read More »

Category: Uncategorized

Preventing postpartum depression: Start with women at greatest risk

January 30, 2019 from ObGynNews The last decade has brought appropriate attention to the high prevalence of postpartum mood and anxiety disorders, with postpartum depression (PPD) constituting the most common complication in modern obstetrics. There have been very substantial efforts in more than 40 states in the United States to enhance screening for PPD and… Read More »

Category: Uncategorized